Sendai, Japan

Toshiyuki Takai

This inventor holds 8 USPTO granted patents and 2 EPO patents. Top assignees: Japan Science and Technology Agency, Japan Science and Technology Corporation. Active years: 2006-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiyuki Takai. Retrieved from https://idiyas.com/inventor/toshiyuki-takai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Innovations of Toshiyuki Takai: Pioneering Nonhuman Model Animals in Research**

Introduction

Toshiyuki Takai, an accomplished inventor based in Sendai, Japan, has contributed significantly to the field of biomedical research with a total of eight patents to his name. His innovative work primarily focuses on creating nonhuman model animals that aid in the understanding of immune responses and neuropsychiatric disorders.

Latest Patents

Among his latest inventions, Takai has developed a "Nonhuman model animal of Th2-mediated hyperimmune response." This model aims to facilitate the analysis of Th2-mediated immune response mechanisms and allergy onset in vivo by utilizing a nonhuman animal lacking the PIR-B gene function. This groundbreaking invention enables researchers to study the hyper-response of B cells and allergies, thereby opening pathways for potential therapeutic interventions.

Another noteworthy patent is the "Non-human animal model of oligodendrocyte developmental disorder." This invention provides methods for preventing and treating neuropsychiatric disorders. The model was created by inducing a deficiency in the DAP12 gene, leading to myelination disorders and neuropsychiatric complications, such as Nasu-Hakola disease. Takai's innovative screening method for therapeutic agents marks a significant stride in the understanding and treatment of such disorders.

Career Highlights

Toshiyuki Takai has held positions at prominent institutions, including the Japan Science and Technology Agency and Japan Science and Technology Corporation. He has been instrumental in advancing research methodologies that harness the capabilities of genetically modified animal models to explore complex biological processes.

Collaborations

Throughout his career, Takai has collaborated with notable coworkers such as Akira Nakamura and Kaori Yajima. These collaborations have undoubtedly enriched his research endeavors, allowing for a multidisciplinary approach to tackling significant challenges in the biomedical field.

Conclusion

Toshiyuki Takai's inventions have the potential to revolutionize the understanding of immune response and neuropsychiatric disorders. His work in developing nonhuman model animals serves not only as a testament to his ingenuity as an inventor but also as a vital resource for future scientific research. With eight patents, his contributions continue to pave the way for innovations that could have lasting impacts on medicine and therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…